Previous 10 | Next 10 |
2023-08-05 14:52:08 ET National Research Corporation (NRC) Q2 2023 Earnings Conference Call August 2, 2023 11:00 ET Company Participants Kevin Karas - Chief Financial Officer Linda Stacy - Vice President, Finance Presentation Operator Hello and we...
2023-08-01 17:03:47 ET National Research press release ( NASDAQ: NRC ): Q2 GAAP EPS of $0.29. Revenue of $36.16M (-3.1% Y/Y). For further details see: National Research GAAP EPS of $0.29, revenue of $36.16M
LINCOLN, Neb., Aug. 01, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2023. Regarding the Company’s 2023 second quarter, Kevin Karas, Chief Financial Officer, said, “Our continued expansion o...
MALVERN, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it pla...
MALVERN, Pa., July 19, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced a healthc...
Lincoln, Nebraska, July 18, 2023 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2023 second quarter earnings conference call on Wednesday, August 2, 2023. The Company’s results for the 2023 secon...
MALVERN, Pa., July 17, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that the Ministry of Food and Drug...
LINCOLN, Neb., July 12, 2023 (GLOBE NEWSWIRE) -- NRC Health has been selected by Bryan Health to be its continuing partner in providing Human Understanding through personalized healthcare solutions and data-driven insights. Through this alliance, NRC Health, recipient of the 2023 Best in ...
MALVERN, Pa., July 11, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is thrilled to announce that its partnership...
MALVERN, Pa., June 12, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced today that they have received 510(...
News, Short Squeeze, Breakout and More Instantly...
National Research Corporation Company Name:
NRC Stock Symbol:
NASDAQ Market:
National Research Corporation Website:
MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that Aetna has updated its TMS (tr...
MALVERN, Pa., July 11, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that California Medicaid (Medi-Cal...
MALVERN, Pa., July 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that updated policies from BlueCro...